U.S. Markets open in 2 hrs 53 mins
  • S&P Futures

    4,414.00
    +24.50 (+0.56%)
     
  • Dow Futures

    34,989.00
    +157.00 (+0.45%)
     
  • Nasdaq Futures

    15,034.25
    +78.50 (+0.52%)
     
  • Russell 2000 Futures

    2,243.90
    +22.30 (+1.00%)
     
  • Crude Oil

    72.84
    -1.11 (-1.50%)
     
  • Gold

    1,811.60
    -5.60 (-0.31%)
     
  • Silver

    25.52
    -0.03 (-0.11%)
     
  • EUR/USD

    1.1892
    +0.0017 (+0.1427%)
     
  • 10-Yr Bond

    1.2390
    0.0000 (0.00%)
     
  • Vix

    18.17
    +0.47 (+2.66%)
     
  • GBP/USD

    1.3905
    -0.0001 (-0.0083%)
     
  • USD/JPY

    109.5330
    -0.0820 (-0.0748%)
     
  • BTC-USD

    39,712.29
    -1,971.71 (-4.73%)
     
  • CMC Crypto 200

    968.10
    +18.20 (+1.92%)
     
  • FTSE 100

    7,098.38
    +66.08 (+0.94%)
     
  • Nikkei 225

    27,781.02
    +497.43 (+1.82%)
     

CBD Can Reduce Nicotine Withdrawal Symptoms, Says New Study Done By CV Sciences

·1 min read

This week, CV Sciences (OTCQB: CVSI) released the results of a preclinical study that suggests that CBD can reduce nicotine withdrawal symptoms in smokeless tobacco users.

The study, conducted in collaboration with researchers from the University of California, San Diego and published on Springer Nature, found that CBD prevented nicotine-dependent rats from exhibiting withdrawal symptoms including increased pain sensitivity and weight gain during short-and long-term nicotine restriction.

The company also released its potential plans to develop the world’s first and only FDA-approved treatment for smokeless tobacco addiction.

“We are thrilled with the results of this study done in collaboration with UC San Diego, which marks a significant milestone for our drug development division,” Joseph Dowling, CEO of CV Sciences told Benzinga. “Through continued research and innovation, we are committed to developing a CBD-based therapeutic to address the huge, unmet medical need and global health issue of nicotine addiction.”

Encuentra nuestro contenido en Español en El Planteo:

Photo: Jon Tyson on Unsplash

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.